HIV-1 gp41: mediator of fusion and target for inhibition
- PMID: 15012000
HIV-1 gp41: mediator of fusion and target for inhibition
Abstract
The bipartite envelope glycoprotein (Env) of the human immunodeficiency virus type 1 (HIV-1) performs two essential functions for initiating virus infection. The gp120 surface subunit of Env binds cell receptors to attach virus to target cells and regulate viral entry. The gp41 transmembrane subunit fuses host-cell and viral membranes to deliver the viral core into the cell cytoplasm. The two subunits derive from a polyprotein precursor, gp160. Cleavage of gp160 in the biosynthetic pathway creates mature Env consisting of the noncovalently-associated gp120/gp41 that is primed for viral entry. While performing distinct operations in HIV entry, the activities of the gp120 and gp41 subunits must be highly coordinated in order to lead to successful infection. This review highlights structure-function relationships in Env, with a focus on the heptad-repeat regions in the ectodomain of gp41. The mechanism of Env-mediated membrane fusion and ways to interfere with this process using inhibitors and antibodies that target gp41 are discussed.
Similar articles
-
Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.Virus Res. 2007 Mar;124(1-2):103-12. doi: 10.1016/j.virusres.2006.10.009. Epub 2006 Nov 28. Virus Res. 2007. PMID: 17129629
-
Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.Biochemistry. 2004 Jun 29;43(25):8230-3. doi: 10.1021/bi049957v. Biochemistry. 2004. PMID: 15209519
-
Antiviral properties of two trimeric recombinant gp41 proteins.Retrovirology. 2006 Mar 3;3:16. doi: 10.1186/1742-4690-3-16. Retrovirology. 2006. PMID: 16515685 Free PMC article.
-
Prospects of HIV-1 entry inhibitors as novel therapeutics.Rev Med Virol. 2004 Jul-Aug;14(4):255-70. doi: 10.1002/rmv.435. Rev Med Virol. 2004. PMID: 15248253 Review.
-
HIV fusion inhibitors.Rev Med Virol. 2010 Jan;20(1):23-33. doi: 10.1002/rmv.631. Rev Med Virol. 2010. PMID: 19827030 Review.
Cited by
-
Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.J Virol. 2022 Apr 13;96(7):e0187821. doi: 10.1128/jvi.01878-21. Epub 2022 Mar 15. J Virol. 2022. PMID: 35289647 Free PMC article.
-
Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition.J Virol. 2008 Nov;82(22):11129-39. doi: 10.1128/JVI.01060-08. Epub 2008 Sep 3. J Virol. 2008. PMID: 18768964 Free PMC article.
-
Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV-1 gp41.Protein Sci. 2014 Nov;23(11):1607-18. doi: 10.1002/pro.2540. Epub 2014 Sep 3. Protein Sci. 2014. PMID: 25155369 Free PMC article.
-
HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses.Viruses. 2019 Nov 1;11(11):1012. doi: 10.3390/v11111012. Viruses. 2019. PMID: 31683782 Free PMC article.
-
Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection.J Virol. 2008 Jun;82(11):5417-28. doi: 10.1128/JVI.02666-07. Epub 2008 Mar 19. J Virol. 2008. PMID: 18353944 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources